Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating activities
Net income	$ 37,045,403	$ 38,710,248
Adjustments to reconcile net income to net cash provided by operating activities:
Accretion of deferred loan origination fees and other discounts	(1,697,139)	(2,983,441)
Paid-in-kind interest	(9,147,837)	(9,458,215)
(Benefit) provision for current expected credit losses	(583,298)	940,385
Change in unrealized loss (gain) on investments	240,604	(75,604)
Realized gain on debt securities, at fair value	(72,428)	(104,789)
Amortization of debt issuance costs	256,998	550,906
Stock based compensation	3,058,674	1,479,736
Changes in operating assets and liabilities:
Interest receivable	(449,683)	200,272
Other receivables and assets, net	185,256	(51,375)
Interest reserve	(3,971,608)	(793,304)
Related party payables	(8,128)	654,016
Related party receivables	(3,263,114)	(107,225)
Purchase of debt securities, at fair value	0	(3,167,020)
Proceeds from the redemption of debt securities, at fair value	839,093	2,505,144
Management and incentive fees payable	(380,617)	(51,825)
Accounts payable and accrued expenses	1,107,200	168,550
Net cash provided by operating activities	23,159,376	28,416,459
Cash flows from investing activities
Issuance of and fundings of loans held for investment	(155,257,974)	(92,201,176)
Principal repayment of loans held for investment	102,461,111	76,876,048
Issuance of and fundings of loans at fair value	(5,500,000)
Proceeds from sale of loans	19,000,000	13,399,712
Net cash used in investing activities	(39,296,863)	(1,925,416)
Cash flows from financing activities
Proceeds from sale of common stock	39,591,879	7,222,363
Proceeds from notes payable	50,000,000
Proceeds from borrowings on revolving loan	159,000,000	82,000,000
Repayment of borrowings on revolving loan	(170,000,000)	(74,000,000)
Dividends paid to common shareholders	(41,632,363)	(39,134,340)
Payment of debt issuance costs	(1,099,231)	(112,279)
Payment of offering costs	(1,220,390)	(284,574)
Net cash provided by/(used in) financing activities	34,639,895	(24,308,830)
Net increase in cash and cash equivalents	18,502,408	2,182,213
Cash and cash equivalents, beginning of period	7,898,040	5,715,827
Cash and cash equivalents, end of period	26,400,448	7,898,040
Supplemental disclosure of non-cash financing and investing activities
Interest reserve withheld from funding of loans	4,194,597	2,238,348
OID withheld from funding of loans held for investment	1,836,952	1,332,340
OID withheld from funding of debt securities, at fair value	0	470,590
Dividends declared and not yet paid	13,605,153	13,866,656
Transfer of loans held for investment to loans held for sale	19,000,000	13,399,712
Non-cash exchange of loans with affiliates	5,960,888
Supplemental information:
Interest paid during the period	$ 6,205,623	$ 5,031,492